Vireo Growth (VREOF) Total Liabilities (2020 - 2026)

Vireo Growth (VREOF) reported Total Liabilities of $634.7 million for Q1 2026, up 180.09% on a YoY basis from $226.6 million in Q1 2025, and up 24.5% sequentially from $509.8 million in Q4 2025.

Vireo Growth (VREOF) Total Liabilities (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Total Liabilities data on file, last reported at $634.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities rose 180.09% year-over-year to $634.7 million; the trailing twelve-month figure through Mar 2026 stood at $634.7 million (up 180.09% YoY), and the FY2025 full-year result was $509.8 million, up 128.3% from the prior year.
  • Total Liabilities rose to $634.7 million in Q1 2026, from $509.8 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $634.7 million in Q1 2026 to a low of $131.6 million in Q1 2022.
  • A 5-year average of $256.5 million and a median of $204.9 million in 2024 frame the typical range for Total Liabilities.
  • Across the five-year window, Total Liabilities gained 6.16% in 2025 and soared 180.09% in 2026, its largest moves.
  • Tracing VREOF's Total Liabilities over 5 years: stood at $155.7 million in 2022, then rose by 27.99% to $199.3 million in 2023, then rose by 12.04% to $223.3 million in 2024, then soared by 128.3% to $509.8 million in 2025, then rose by 24.5% to $634.7 million in 2026.
  • Business Quant data shows VREOF's Total Liabilities at $634.7 million in Q1 2026, $509.8 million in Q4 2025, and $432.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.48 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 31.81 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 11.92 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 51.53 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 813.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 22.18 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.50 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.72 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 634.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 634.70 Mn
Dec 31, 2025 509.80 Mn
Sep 30, 2025 432.61 Mn
Jun 30, 2025 390.76 Mn
Mar 31, 2025 226.61 Mn
Dec 31, 2024 223.30 Mn
Sep 30, 2024 204.87 Mn
Jun 30, 2024 217.24 Mn
Mar 31, 2024 213.46 Mn
Dec 31, 2023 199.31 Mn
Sep 30, 2023 184.52 Mn
Jun 30, 2023 173.88 Mn
Mar 31, 2023 160.70 Mn
Dec 31, 2022 155.72 Mn
Sep 30, 2022 156.85 Mn
Jun 30, 2022 144.83 Mn
Mar 31, 2022 131.65 Mn
Dec 31, 2021 123.96 Mn
Sep 30, 2021 113.25 Mn
Jun 30, 2021 56.43 Mn